The BD MAX™ System is a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 patient samples across multiple syndromes in approximately three hours.
BD offers a suite of clinically relevant, differentiated in vitro diagnostic assays in the areas of Women’s Health and Sexually-Transmitted Infections, Enteric Infections, and Healthcare-Associated Infections. The current menu aids institutions and clinicians in addressing a wide range of complex patient cases, while the innovative pipeline plans to bring forth future assays to continue to provide comprehensive testing solutions globally. Expand your laboratory’s molecular solutions with the BD MAX™ System to help your clinicians set their patients on the right clinical path.
Optimize workflow to improve care. Patient wait time is a source of concern. Manual methods plus multiple instruments mean a longer time for results. Delays may lead to inefficient patient management. The BD MAX™ System offers simple implementation and standardized workflow, requiring less than one minute of hands-on time per specimen.
Improve patient care with speed and accuracy. Traditional methods are slower or less sensitive, which can contribute to inappropriate or ineffective treatment and extended hospital stays for patients. The BD MAX™ System can support improved patient outcomes, reduce healthcare costs, and significantly advance antimicrobial stewardship strategies.
One system with the ability to provide a variety of testing options for infection control, an expanding offering to keep up with emerging diagnostic requirements, and tailored options based on needs. The BD MAX™ System is capable of processing multiple specimen types and assays in a single run.